Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Endoscopic Submucosal Dissection Market size is expected to expand from USD 372.68 million in 2024 to USD 756.78 million by 2037, reflecting a CAGR of over 5.6% during the forecast timeline, from 2025 to 2037. Currently in 2025, the industry revenue of endoscopic submucosal dissection is assessed at USD 387.29 million.
The primary growth driver for the market is the relentless evolution of technology within endoscopy procedures. The continuous refinement of tools and imaging capabilities in the field of ESD not only enhances the precision of diagnostic procedures but also significantly improves the efficacy of therapeutic interventions.
Furthermore, advancements in electrosurgical tools, incorporating features like tissue-specific energy delivery and enhanced cutting capabilities, contribute to the procedural efficiency and safety of ESD. These innovations empower healthcare professionals to perform intricate dissections with reduced collateral damage to surrounding tissues, thereby optimizing patient outcomes. According to a recent report, the U.S. was the biggest exporter of medical technology devices in the world.
Additionally, ESD is a minimally invasive technique used for the removal of early-stage gastrointestinal tumors, particularly in the esophagus, stomach, and colorectal region.
Endoscopic Submucosal Dissection Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing incidence of gastrointestinal diseases - The rising incidence of gastrointestinal diseases, specifically colorectal cancer and gastric cancer, is a significant growth driver for the endoscopic submucosal dissection (ESD) market. According to a recent report, there were an estimated 1.8 million new cases of colorectal cancer worldwide in 2020.
- Moreover, this escalating prevalence underscores the urgent need for advanced diagnostic and therapeutic interventions, such as ESD. As these diseases continue to affect a growing number of individuals globally, the endoscopic submucosal dissection market is positioned to play a crucial role in their management and treatment.
- Preference for minimally invasive procedures - The global shift towards minimally invasive procedures is a driving force for the ESD market. An increase has been noted in the preference for minimally invasive interventions over traditional surgeries in the last decade. Patients and healthcare providers favor these procedures due to their associated benefits, including shorter recovery times, reduced postoperative complications, and improved overall patient outcomes. Growing preference positions ESD as a forefront choice in gastrointestinal interventions, further fueling market growth.
- Technological advancements in endoscopic tools - Continuous innovation in endoscopic tool is a pivotal growth driver for the endoscopic submucosal dissection market. Advanced tools, including robotic-assisted platforms and high-definition diagnostic imaging systems, are transforming the landscape of gastrointestinal interventions.
- Furthermore, this highlights the tangible impact of technological advancements on enhancing the precision and outcomes of ESD interventions, making them more attractive to healthcare providers and patients alike. Growing awareness regarding the importance of early diagnosis of gastrointestinal diseases contributes to the demand for diagnostic procedures like ESD.
Challenges
- Procedural complexity and skill requirement: Performing ESD procedures requires a high level of skill and expertise. The intricate nature of the dissection process demands advanced training for endoscopists, making it a challenging technique for widespread implementation.
- The limited availability of highly skilled professionals may hinder the accessibility of ESD procedures, particularly in regions with a shortage of trained endoscopists. Healthcare facilities, especially in resource-constrained settings, may find it challenging to invest in ESD technology, limiting its accessibility to a broader patient population.
- The higher cost of equipment and training hinders the market growth
- Lack of awareness among patients restricts the use of ESD
Endoscopic Submucosal Dissection Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.6% |
|
Base Year Market Size (2024) |
USD 372.68 million |
|
Forecast Year Market Size (2037) |
USD 756.78 million |
|
Regional Scope |
|
Endoscopic Submucosal Dissection Segmentation
Product (Gastroscopes & Colonoscopes, Knives, Injection Agents)
The gastroscopes & colonoscopes segment in the endoscopic submucosal dissection market is estimated to gain a revenue share of 60% in the year 2037. The segment growth can be attributed to the ongoing advancements in colonoscopic techniques, including improved maneuverability and visualization capabilities, which contribute to the success rates of ESD procedures. With the aging global population, there is a corresponding increase in the prevalence of colorectal diseases.
Colonoscopes have become indispensable tools in addressing the higher incidence of colorectal cancer and other gastrointestinal conditions in the elderly population. The age-related rise in colorectal diseases contributes to the sustained growth of the colonoscope segment within the ESD market. They are integral to the detection and treatment of colorectal cancer through ESD procedures. The alarming rise in colorectal cancer incidence worldwide underscores the crucial role of colonoscopes in early diagnosis and intervention. The American Cancer Society reported over 147,000 new cases of colorectal cancer in the United States in 2020.
End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)
The hospital segment in the endoscopic submucosal dissection market is expected to garner a significant share in the year 2037 due to the increasing awareness among patients regarding minimally invasive treatment options that fuels the demand for ESD procedures. In addition, hospitals, as primary healthcare providers, witness a surge in patients seeking advanced, less invasive alternatives. To meet this demand, hospitals invest in the necessary infrastructure, training, and technology, positioning themselves at the forefront of ESD adoption and growth.
Furthermore, government initiatives and healthcare policies play a pivotal role in shaping the healthcare landscape, including the adoption of advanced medical procedures like ESD. Various supportive policies and funding initiatives encourage hospitals to invest in infrastructure and training for ESD procedures. As governments prioritize the improvement of healthcare services, hospitals become key beneficiaries, driving growth in the hospitals segment. The hospital, as hubs for medical innovation and advancement, are quick to adopt cutting-edge technologies.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
End User |
|
|
Indication |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportEndoscopic Submucosal Dissection Industry - Regional Synopsis
APAC Market Forecast
The endoscopic submucosal dissection market in the Asia Pacific region is projected to hold the largest revenue share of 47% by the end of 2037. The Asia Pacific region, particularly countries like Japan, China, and South Korea, experiences a disproportionately high burden of gastric cancer. Moreover, the prevalence of this disease creates a substantial market for ESD procedures, which are increasingly recognized as effective interventions for early-stage gastric cancer. The pressing need to address the high incidence of gastric cancer serves as a primary growth driver for the ESD market in the Asia Pacific region. According to a recent report, Asia accounts for nearly 50% of the global incidence of gastric cancer.
The region is at the forefront of adopting cutting-edge endoscopic technologies. The ongoing advancements, including high-definition imaging and real-time monitoring, enhance the precision and success rates of ESD procedures. This commitment to technological progress positions the region as a hub for innovation in endoscopy, driving growth in the ESD market.
North American Market Statistics
The endoscopic submucosal dissection market in the North American region is projected to hold the second-largest share during the forecast period. Colorectal cancer is a significant health concern in North America, particularly in the United States. The high incidence of colorectal cancer creates a substantial demand for effective treatment methods such as ESD. As a result, healthcare providers in North America are increasingly adopting ESD procedures as an essential tool in the fight against colorectal cancer.
North America is at the forefront of integrating cutting-edge technologies into healthcare practices. Continuous advancements in endoscopic imaging technologies, including high-definition scopes and advanced software, enhance the precision of ESD procedures. This commitment to technological innovation positions North America as a hub for advanced endoscopic techniques, driving growth in the ESD market.
The prevalence of GERD in North America contributes to a higher incidence of Barrett's esophagus and other gastrointestinal conditions. ESD procedures are increasingly recognized as effective interventions for treating early-stage lesions associated with GERD. As a result, the demand for ESD in North America is fueled by the need to address GERD-related complications.
Companies Dominating the Endoscopic Submucosal Dissection Landscape
- Olympus Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Fujifilm Holdings Corporation
- Boston Scientific Corporation
- Medtronic plc
- Cook Medical
- Hoya Corporation
- Karl Storz GmbH & Co. KG
- CONMED Corporation
- ERBE Elektromedizin GmbH
- Johnson & Johnson
In the News
- Medtronic plc - The global leader in healthcare technology, Medtronic plc announced that it has expanded its partnership with Cosmo Intelligent Medical Devices which is a subsidiary of Cosmo Pharmaceuticals. This partnership aims to revolutionize endoscopy by the integration of AI to improve patients’ outcomes. The collaboration also focused on innovative AI platforms like AI Access to host multiple third party AI applications.
- Johnson & Johnson - Johnson & Johnson and Shockwave Medical have entered into an agreement in which Johnson & Johnson will acquire shares of Shockwave. This acquisition of Shockwave extends the company’s MedTech’s position in cardiovascular intervention. Additionally, the acquisition will complement the company’s leadership position in heart recovery to make it a category leader in the MedTech markets within the cardiovascular intervention.
Author Credits: Radhika Pawar
- Report ID: 5662
- Published Date: Mar 20, 2025
- Report Format: PDF, PPT
